1. AstraZeneca pays Sobi $95M for priority review voucher — Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study — Retrophin sinks as drug “Pharma Bro” Martin Shkreli co-invented fails — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Momentum Consulting

Anonymous board for Momentum Consulting

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    4
    Views:
    1,232
  2. anonymous
    Replies:
    0
    Views:
    362
  3. anonymous
    Replies:
    0
    Views:
    498

Thread Display Options

Loading...